Genetic Mutations and Family History
704 articles
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day One
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
New Liquid Biopsy Shows Promise for Early Detection
Dr. Ajay Goel has a new approach to a liquid biopsy early detection test for pancreatic cancer. So far, the results are very impressive.
2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.
Drafting Your Health Care Team
If you have pancreatic cancer, a treatment team of experts from across the medical profession will make sure you get the best care.
Finding a Treatment Geared to My Cancer
Samuel Chi describes his search for a pancreatic cancer treatment that allows him to live comfortably and reduce his tumor so he can have surgery.
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day Two
Let’s Win and the Lustgarten Foundation bring you the highlights from Day Two of the AACR special conference on pancreatic cancer.
Testing a Signal-Inhibiting Drug on Tumors with Specific Mutations
A new drug for certain tumor mutations is being tested in a type of clinical trial called a basket trial, which matches tumor genetics and drugs.
COVID-19: What You Should Do Now
Learn what you should do to prevent the spread of COVID-19, especially if you have a weakened immune system from pancreatic cancer treatment.
New Biopsy Shows Promise For Pancreatic Cancer Patients
Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.
Surviving Pancreatic Cancer and Inspiring Others
When John O’Grady realized he was going to survive pancreatic cancer, he beganinto helping other patients by volunteering with PanCAN and making quilts.
An Expanded Access Trial for Cancer Patients with Specific Mutations
An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.
Your Survival Depends on Taking Control of What You Can
Sharon Orleans Lawrence outlines her search for stage IV pancreatic cancer treatment. She chooses low-dose chemotherapy, which made her life comfortable.
Meet the Researcher: Arnav Mehta, M.D., Ph.D.
Dr. Arnav Mehta combines mathematics and medicine in his search to improve options for gastrointestinal cancer patients. Learn about his groundbreaking work.
New AI Tool Brings Hope in Quest for Earlier Detection
Can AI help catch pancreatic cancer at an earlier stage? Dr. Michael Rosenthal and others are working on an AI tool to do just that.
Endurance Athlete Enduring Pancreatic Cancer Treatment
After a stage IV pancreatic cancer diagnosis, Dr. Kevin Moore had cytoreductive surgery to remove the metastases in his abdomen.